I. Moutard et al., In vitro effects of spiramycin and dirithromycin on IL1 beta production byhuman LPS-stimulated mononuclear cells, THERAPIE, 54(5), 1999, pp. 607-612
Polymorphonuclear neutrophils are the predominant cells in acute inflammato
ry lesions and their functions and recruitment are regulated by cytokines,
including IL1, TNF and IL8. Antibiotic modulation of inflammatory effects h
as stimulated investigations of antibiotics for their potential activity as
immunomodulators over their primary bactericidal or bacteriostatic activit
ies. This study reports the influence of macrolides, spiramycin and dirithr
omycin on IL1 beta production, Mononuclear cells, isolated from healthy hum
an volunteers, were preincubated with macrolides (0.1 to 500 mu g/ml) and s
timulated by Escherichia coli lipopolysaccharide. Then, IL1 beta production
was detected by western blotting analysis. At therapeutic concentrations,
dirithromycin and spiramycin seemed to enhance IL1 beta production by LPS-s
timulated cells, with +37 per cent and +28 per cent at 1 mu g/ml respective
ly. At supratherapeutic concentrations, these drugs seemed to inhibit IL1 b
eta production through protein kinase C inhibition, with inhibitory concent
rations 50 per cent of 378 mu g/ml for dirithromycin and 234 mu g/ml for sp
iramycin. So, macrolides may modulate the host defence system through their
influence on cytokine production.